Acute neuropathy mimicking porphyria induced by aminolevulinic acid during photodynamic therapy

Muscle and Nerve

Volumn 31, Issue 3, 2005, Pages 390-393

  Sylantiev, Constantin ^a   Schoenfeld, Nili ^b,c   Mamet, Rivka ^b   Groozman, Galina B ^a   Drory, Vivian E ^a,c  

^a TEL AVIV SOURASKY MEDICAL CENTER   (Israel)

^b RABIN MEDICAL CENTER   (Israel)

^c TEL AVIV UNIVERSITY   (Israel)

Author keywords

Aminolevulinic acid; Photodynamic therapy; Polyneuropathy; Porphyria

Indexed keywords

AMINOLEVULINIC ACID; PRODRUG;

AGED; ARTICLE; AUTONOMIC NEUROPATHY; BARRETT ESOPHAGUS; CASE REPORT; DIFFERENTIAL DIAGNOSIS; DISEASE SEVERITY; HEME SYNTHESIS; HUMAN; LABORATORY TEST; MALE; MOTOR NEUROPATHY; NEUROPATHY; PHOTODYNAMIC THERAPY; PORPHYRIA; PRIORITY JOURNAL; SKIN MANIFESTATION; SYMPTOMATOLOGY;

ACUTE DISEASE; AGED; AGED, 80 AND OVER; AMINOLEVULINIC ACID; BARRETT ESOPHAGUS; DIAGNOSIS, DIFFERENTIAL; HUMANS; MALE; NERVOUS SYSTEM DISEASES; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; PORPHYRIAS;

EID: 13844322275     PISSN: 0148639X     EISSN: None     Source Type: Journal    
DOI: 10.1002/mus.20167     Document Type: Article

References (18)

1. Albers JW, Robertson WC, Daube JR. Electrodiagnostic findings in acute porphyric neuropathy. Muscle Nerve 1978;1:292-296.
2. Albers JW, Fink JK. Porphyric neuropathy. Muscle Nerve (to be published).
3. Barohn RJ, Sanchez JA, Anderson KE. Acute peripheral neuropathy due to hereditary coproporphyria. Muscle Nerve 1994;17:793-799.
4. Bonkovsky HL. Advances in understanding and treating the little imitator, acute porphyria. Gastroenterology 1993;105:590-594.
5. Desnick RJ. The porphyrias. In: Fauci AS, Braunwald E, Isselbacher KJ, Wilson JD, Martin JB, Kasper DL, Hauser SL, Lange DL, editors. Harrison's principles of internal medicine. New York: McGraw Hill; 1998. p 2152-2158.
6. Elder GH, Hift RJ, Meissner PN. The acute porphyrias. Lancet 1997;349:1613-1617.
7. Hopper C. Photodynamic therapy: a clinical reality in the treatment of cancer. Lancet Oncol 2000;1:212-219.
8. Jacob K, Egeler E, Gross U, Doss MO. Investigations on the formation of urinary coproporphyrin isomers I-IV in 5-aminolevulinic acid dehydratase deficiency porphyria, acute lead intoxication and after oral 5-aminolevulinic acid loading. Clin Biochem 1999;32:119-123.
9. Kelty CJ, Brown NJ, Reed MN, Ackroyd R. The use of 5-aminolaevulinic acid as a photosensitizer in photodynamic therapy and photodiagnosis. Photochem Photobiol Sci 2002;1:158-168.
10. Kelty CJ, Marcus SL, Ackroyd R. Photodynamic therapy for Barrett's esophagus: a review. Dis Esophagus 2002;15:137-144.
11. Mercelis R, Hassoun A, Verstraeten L, De Bock R, Martin JJ. Porphyric neuropathy and hereditary delta-aminolevulinic acid dehydratase deficiency in an adult. J Neurol Sci 1990;95:39-47.
12. Meyer UA, Schuurmans MM, Lindberg RL. Acute porphyrias: pathogenesis of neurological manifestations. Semin Liver Dis 1998;18:43-52.
13. Moore MR, Hift RJ. Drugs in the acute porphyrias - toxicogenetic diseases. Cell Mol Biol 1997;43:89-94.
14. Mustajoki P, Kauppinen R, Lannfelt L, Lilius L, Koistinen J. Frequency of low erythrocyte porphobilinogen deaminase activity in Finland. J Int Med 1992;231:389-395.
15. Mustajoki P, Timonen K, Gorchein A, Seppalainen AM, Matikainen E, Tenhunen R. Sustained plasma 5-aminolaevulinic acid concentration in a volunteer: no porphyric symptoms. Eur J Clin Invest 1992;22:407-411.
16. Spechler SJ. Barrett's esophagus and esophageal adenocarcinoma: pathogenesis, diagnosis and therapy. Med Clin North Am 2002;86:1423-1445.
17. Webber J, Kessel D, Fromm D. Side effects and photosensitization of human tissues after aminolevulinic acid. J Surg Res 1997;68:31-37.
18. Wochnik-Dyjas D, Niewiadomska M, Kostrzewska E. Porphyric polyneuropathy and its pathogenesis in the light of electrophysiological investigations. J Neurol Sci 1978;35:243-256.